Position in EDIT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$751,119
+$418,000 QoQ
Shares Held
231,827
+71.9% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 216 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Sep 30, 2021CallValue
$3,142,620
CallShares
76,500
PutValue
$4,703,660
PutShares
114,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. EDIT ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in EDIT
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $751,119 | 231,827 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $333,119 | 134,866 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $397,032 | 193,675 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $2,375,330 | 1,079,696 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,760,478 | 1,517,655 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $550,127 | 433,172 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,008,432 | 882,239 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,520,517 | 539,726 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,653,118 | 896,647 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,769,208 | 372,084 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,562,516 | 328,528 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,523,533 | 428,133 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,828,737 | 941,895 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,638,533 | 861,165 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,615,733 | 458,802 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,487,907 | 294,836 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,801,649 | 305,029 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,246,686 | 272,945 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,142,620 | 76,500 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $4,703,660 | 114,500 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $12,444,280 | 302,928 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,714,014 | 242,126 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $8,948,394 | 213,057 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $9,358,631 | 133,485 | Shares | Defined | 2021-02-10 | |
| 2020-12-31 | $3,519,522 | 50,200 | Put | Defined | 2021-02-10 | |
| 2020-12-31 | $1,198,881 | 17,100 | Call | Defined | 2021-02-10 | |
| 2020-09-30 | $952,636 | 33,950 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,476,329 | 117,523 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $811,818 | 40,939 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||